Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
DEC003M in Advanced Prostate Carcinoma: NCT07657806 Clinical Landscape Report 2026
28 September 2026
NCT07657806 clinical landscape for Advanced Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pralsetinib in Metastatic Solid Tumor: NCT07704658 Clinical Landscape Report 2026
28 September 2026
NCT07704658 clinical landscape for Metastatic Solid Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Alvespimycin Hydrochloride in Kidney Failure, Chronic: NCT07663279 Clinical Landscape Report 2026
28 September 2026
NCT07663279 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab tirumotecan in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07702305 Clinical Landscape Report 2026
28 September 2026
NCT07702305 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
9 min read
Finerenone in Diabetes Mellitus, Type 2: NCT07667517 Clinical Landscape Report 2026
28 September 2026
NCT07667517 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Serplulimab in Locally Advanced Gastroesophageal Junction Adenocarcinoma: NCT07674342 Clinical Landscape Report 2026
28 September 2026
NCT07674342 clinical landscape for Locally Advanced Gastroesophageal Junction Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context a…
9 min read
AD-236A (Addpharma, Inc.) in Diabetes Mellitus, Type 2: NCT07730567 Clinical Landscape Report 2026
28 September 2026
NCT07730567 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tirzepatide in Type 2 diabetes mellitus in obese: NCT07728318 Clinical Landscape Report 2026
28 September 2026
NCT07728318 clinical landscape for Type 2 diabetes mellitus in obese: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Semaglutide (Novo Nordisk) in Diabetes Mellitus, Type 2: NCT07732218 Clinical Landscape Report 2026
28 September 2026
NCT07732218 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sintilimab in Locally Advanced Rectal Carcinoma: NCT07738042 Clinical Landscape Report 2026
28 September 2026
NCT07738042 clinical landscape for Locally Advanced Rectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Benzydamine Hydrochloride in radiation oral mucositis: NCT07748442 Clinical Landscape Report 2026
28 September 2026
NCT07748442 clinical landscape for radiation oral mucositis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nivolumab in Squamous Cell Carcinoma of Head and Neck: NCT07741565 Clinical Landscape Report 2026
28 September 2026
NCT07741565 clinical landscape for Squamous Cell Carcinoma of Head and Neck: endpoints, sponsor, phase, geography, readouts, asset context and development wh…